Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: A quantitative review

Journal of Consulting and Clinical Psychology

Volumn 65, Issue 1, 1997, Pages 44-52

  Abramowitz, Jonathan S ^a,b  

^a UNIVERSITY OF MEMPHIS   (United States)

^b University of Memphis   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIFENE; FLUOXETINE; FLUVOXAMINE; SEROTONIN AGONIST; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSESSION; RELAXATION TRAINING; TREATMENT OUTCOME;

BEHAVIOR THERAPY; CLOMIPRAMINE; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIALS; HUMANS; OBSESSIVE-COMPULSIVE DISORDER; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 0031016168     PISSN: 0022006X     EISSN: None     Source Type: Journal    
DOI: 10.1037/0022-006X.65.1.44     Document Type: Article

References (69)

1. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
2. * Anath, J., Pecknold, J. C., van den Steen, N., & Engelsmann, F. (1981). Double-blind comparative study of clomipramine and amitriptyline in obsessive neurosis. Progress in Neuro-Psychopharmacology, 5, 257-262.
3. Beck, A. T. (1976). Cognitive therapy and the emotional disorder. New York: International Universities Press.
4. * Chouinard, G., Goodman, W., Greist, J., Jenike, M., Rasmussen, S., White, K., Hackett, E., Gaffney, M., & Bick, P. A. (1990). Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder. Psychopharmacology Bulletin, 26, 279-284.
5. Christensen, H., Hadzi-Pavlovic, D., Andrews, G., & Mattick, R. (1987). Behavior therapy and tricyclic medication in the treatment of obsessive-compulsive disorder: A quantitative review. Journal of Consulting and Clinical Psychology, 55, 701-711.
6. * The Clomipramine Collaborative Study Group. (1991). Clomipramine in the treatment of patients with obsessive-compulsive disorder. Archives of General Psychiatry; 48, 730-738.
7. Cohen, J. (1977). Statistical power analysis for the behavioral sciences (rev. ed.). New York: Academic Press.
8. Cottraux, J., Mollard, E., Bouvard, M., Marks, I., Sluys, M., Nury, A., Douge, R., & Cialdella, P. (1990). A controlled study of fluvoxamine and exposure in obsessive-compulsive disorder. International Clinical Psychopharmacology, 5, 17-30.
9. * DeVeaugh-Geiss, J., Katz, R., Landau, P., Goodman, W., & Rasmussen, S. (1990). Clinical predictors of treatment response in obsessive-compulsive disorder: Exploratory analyses from multicenter trials of clomipramine. Psychopharmacology Bulletin, 26, 54-59.
10. Ellis, A. (1994). Rational emotive behavior therapy approaches to obsessive-compulsive disorder (OCD). Journal of Rational-Emotive and Cognitive-Behavior Therapy, 12, 121-141.
11. * Emmelkamp, P. M. G., & Beens, H. (1991). Cognitive therapy with obsessive-compulsive disorder: A comparative evaluation. Behavior Research and Therapy, 29, 293-300.
12. Emmelkamp, P. M. G., & Kuipers, A. C. M. (1979). Agoraphobia: A follow-up study four years after treatment. British Journal of Psychiatry, 134, 352-255.
13. * Emmelkamp, P. M. G., Visser, S., & Hoekstra, R. J. (1988). Cognitive therapy vs. exposure in vivo in the treatment of obsessive-compulsives. Cognitive Therapy and Research, 12, 103-114.
14. * Fals-Stewart, W., Marks, A. P., & Schafer, J. (1993). A comparison of behavioral group therapy and individual behavior therapy in treating obsessive-compulsive disorder. The Journal of Nervous and Mental Disease, 181, 189-193.
15. Feske, U., & Chambliss, D. L. (1995). Cognitive behavioral versus exposure only treatment for social phobia: A meta-analysis. Behavior Therapy, 26, 695-720.
16. Fisher, S., & Greenberg, R. P. (1993). How sound is the double-blind design for evaluating psychotropic drugs? The Journal of Nervous and Mental Disease, 181, 345-350.
17. Foa, E. B., & Chambliss, D. L. (1978). Habituation of anxiety during flooding in imagery. Behavior Research and Therapy, 16, 391-399.
18. Foa, E. B., & Goldstein, A. (1978). Continuous exposure and complete response prevention in the treatment of obsessive-compulsive neurosis. Behavior Therapy, 9, 821-829.
19. Foa, E. B., & Kozak, M. J. (1986). Emotional processing of fear: Exposure to corrective information. Psychological Bulletin, 99, 20-35.
20. * Foa, E. B., Steketee, G. S., Grayson, J. B., Turner, R. M., & Lattimer, P. R. (1984). Deliberate exposure and blocking of obsessive-compulsive rituals: Immediate and long-term effects. Behavior Therapy, 15, 450-472.
21. * Foa, E. B., Steketee, G. S., Kozak, M. J., & Dugger, D. (1987). Imipramine and placebo in the treatment of obsessive-compulsives: Their effect on depression and on obsessional symptoms. Psychopharmacology Bulletin, 23, 8-11.
22. Glass, G. V., McGaw, B., & Smith, M. L. (1981). Meta-analysis in social research. Beverly Hills, CA: Sage.
23. * Goodman, W. K., Price, L. H., Rasmussen, S. A., Delgado, P. L., Heninger, G. R., & Charney, D. S. (1989). Efficacy of fluvoxamine in obsessive-compulsive disorder. Archives of General Psychiatry, 46, 36-44.
24. Goodman, W. K., Price, L. H., Rasmussen, S. A., Mazure, C., Fleischmann, R. L., Hill, C. L., Heninger, G. R., & Charney, D. S. (1989). The Yale-Brown Obsessive-Compulsive Scale I: Development, use, and reliability. Archives of General Psychiatry, 46, 1006-1011.
25. Greenberg, R. P., Bornstein, R. F., Greenberg, R. P., & Fisher, S. (1992). A meta-analysis of antidepressant medication under "blinder" conditions. Journal of Consulting and Clinical Psychology, 60, 664-669.
26. Greenberg, R. P., Bomstein, R. F., Zborowski, M. J., Fisher, S., & Greenberg, M. D. (1994). A meta-analysis of fluoxetine outcome in the treatment of depression. The Journal of Nervous and Mental Disease, 182, 547-551.
27. * Greist, J. H., Jefferson, J. W., Rosenfeld, R., Gutzman, L. D., March, J. S., & Barklage, N. E. (1990). Clomipramine and obsessive-compulsive disorder: A placebo-controlled double-blind study of 32 patients. Journal of Clinical Psychiatry, 51, 292-297.
28. * Hackman, A., & McLean, C. (1975). A comparison of flooding and thought stopping in the treatment of obsessional neurosis. Behavior Research and Therapy, 13, 263-269.
29. Hedges, L. V. (1982). Estimation of effect size from a series of independent experiments. Psychological Bulletin, 92, 490-499.
30. Insel, T. R., Mueller, E. A., Alterman, I., Linnoila, M., & Murphy, D. L. (1985). Obsessive-compulsive disorder and serotonin: Is there a connection? Biological Psychiatry, 20, 1174-1188.
31. * Insel, T. R., Murphy, D. L., Cohen, R. M., Alterman, I., Kilts, C., & Linnoila, M. (1983). Obsessive-compulsive disorder: A double-blind trial of clomipramine and clorgyline. Archives of General Psychiatry, 40, 605-612.
32. Jenike, M. A., Baer, L., & Griest, J. H. (1990). Clomipramine versus fluoxetine in obsessive-compulsive disorder: A retrospective comparison of side-effects and efficacy. Journal of Clinical Psychopharmacology, 10, 122-124.
33. * Jenike, M. A., Baer, L., Summergrad, P., Minichiello, W. E., Holland, A., & Seymour, R. (1990). Sertraline in obsessive-compulsive disorder: A double-blind comparison with placebo. American Journal of Psychiatry, 147, 923-928.
34. * Jenike, M. A., Baer, L., Summergrad, P., Weilburg, J. B., Holland, A., & Seymour, R. (1989). Obsessive-compulsive disorder: A double-blind, placebo-controlled trial of clomipramine in 27 patients. American Journal of Psychiatry, 146, 1328-1330.
35. * Jenike, M. A., Hyman, S., Baer, L., Holland, A., Minichiello, W. E., Buttolph, L., Summergrad, P., Seymour, R., & Ricciardi, J. (1990). A controlled trial of fluvoxamine in obsessive-compulsive disorder: Implications for a serotonergic theory. American Journal of Psychiatry, 147, 1209-1215.
36. Karno, M., Golding, J., Sorenson, S., & Burnam, M. A. (1988). The epidemiology of obsessive-compulsive disorder in five U. S. communities. Archives of General Psychiatry, 45, 1094-1099.
37. * Katz, R. J., DeVeaugh-Geiss, J., & Landau, P. (1990). Clomipramine in obsessive-compulsive disorder. Biological Psychiatry, 28, 401-414.
38. Koopmans, P. C., Sanderman, R., Timmerman, I., & Emmelkamp, P. M. G. (1994). The Irrational Beliefs Inventory: Development and psychometric evaluation. European Journal of Psychological Assessment, in press.
39. Lipsey, M. W., & Wilson, D. B. (1993). The efficacy of psychological, educational, and behavioral treatment: Confirmation from meta-analysis. American Psychologist, 48, 1181-1209.
40. * Mallya, G. K., White, K., Waternaux, C., & Quay, S. (1992). Short and long-term treatment of obsessive-compulsive disorder with fluvoxamine. Annals of Clinical Psychiatry, 4, 77-80.
41. Marks, I. M., Lelliott, P., Basoglu, M., Noshirvani, H., Monteiro, W., Cohen, D., & Kasvikis, Y. (1988). Clomipramine, self-exposure and therapist-aided exposure for obsessive-compulsive rituals. British Journal of Psychiatry, 152, 522-534.
42. * Mavissakalian, M., Jones, B., Olson, S., & Perel, J. M. (1990). Clomipramine in obsessive-compulsive disorder: Clinical response and plasma levels. Journal of Clinical Psychopharmacology, 10, 261-268.
43. Mavissakalian, M., Turner, S. M., Michelson, L. & Jacob R. (1985). Tricyclic antidepressants in obsessive-compulsive disorder: Antiobsessional or antidepressant agents? II. American Journal of Psychiatry, 142, 572-576.
44. * McDougle, C. J., Goodman, W. K., Leckman, J. F., Lee, N. C., Heninger, G. R., & Price, L. H. (1994). Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. Archives of General Psychiatry, 51, 302-308.
45. Minichiello, W. E., Baer, L., Jenike, M. A., & Holland, A. (1990). Journal of Anxiety Disorders, 4, 147-150.
46. * Montgomery, S. A., McIntyre, A., Osterheider, M., Sarteschi, P., Zitterl, W., Zohar, J., Birkett, M., Wood, A. J., & The Lilly European OCD Study Group. (1993). A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder. European Neuropsychopharmacology, 3, 142-152.
47. * Pato, M. T., Pigott, T. A., Hill, J. L., Grover, G. N., Bernstein, S., & Murphy, D. L. (1991). American Journal of Psychiatry, 148, 127-129.
48. Perse, T. (1988). Obsessive-compulsive disorder: A treatment review. Journal of Clinical Psychiatry, 49, 48-55.
49. * Perse, T. L., Greist, J. H., Jefferson, J. W., Rosenfeld, R., & Dar, R. (1987). Fluvoxamine treatment of obsessive-compulsive disorder. American Journal of Psychiatry, 144, 1543-1548.
50. * Pigott, T. A., L'Heureux, F., Rubenstein, C. S., Bernstein, S. E., Hill, J. L., & Murphy, D. L. (1992). A double-blind, placebo controlled study of trazodone in patients with obsessive-compulsive disorder. Journal of Clinical Psychopharmacology, 12, 156-162.
51. * Pigott, T. A., Pato, M. T., Bernstein, S. E., Grover, G. N., Hill, J. L., Tolliver, T. J., & Murphy, D. L. (1990). Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Archives of General Psychiatry, 47, 926-932.
52. Rachman, S., & Hodgson, R. (1980). Obsessions and compulsions. Englewood Cliffs, NJ: Prentice Hall.
53. Rasmussen, S. A., & Tsuang, M. T. (1986). Clinical characteristics and family history in DSM-III obsessive-compulsive disorder. American Journal of Psychiatry, 143, 317-322.
54. Riggs, D. S., & Foa, E. B. (1993). Obsessive-compulsive disorder. In D. H. Barlow (Ed.), Clinical handbook of psychological disorders (2nd ed., pp. 189-239). New York: Guilford Press.
55. Rosenfeld, R., Dar, R., Anderson, D., Kobak, K. A., & Greist, J. H. (1992). A computer-administered version of the Yale-Brown Obsessive-Compulsive Scale. Psychological Assessment, 4, 329-332.
56. Salkovskis, P. M. (1985). Obsessional-compulsive problems: A cognitive-behavioral analysis. Behaviour Research and Therapy, 23, 571-584.
57. Salkovskis, P. M. (1989). Cognitive-behavioural factors and the persistence of intrusive thoughts in obsessional problems. Behaviour Research and Therapy, 27, 677-682.
58. * Smiraldi, E., Erzegovesi, S., Bianchi, I., Pasquali, L., Cocchi, S., & Ronchi, P. (1992). Fluvoxamine vs. clomipramine treatment in obsessive-compulsive disorder. New Trends in Experimental and Clinical Psychiatry, 8, 63-65.
59. Stanley, M. A., & Turner, S. M. (1995). Current status of pharmacological and behavioral treatment of obsessive-compulsive disorder. Behavior Therapy, 26, 163-186.
60. * Stein, D. J., Hollander, E., Mullen, L. S., DeCaria, C. M., & Liebowitz, M. R. (1992). Comparison of clomipramine, alprazolam and placebo in the treatment of obsessive-compulsive disorder. Human Psychopharmacology, 7, 389-395.
61. Steketee, G. S. (1993). Treatment of obsessive-compulsive disorder. New York: Guilford Press.
62. * Thoren, P., Asberg, M., Cronholm, B., Jornestedt, L., & Traskman, L. (1980). Clomipramine treatment of obsessive-compulsive disorder. Archives of General Psychiatry, 37, 1281-1285.
63. * Tollefson, G. D., Rampey, A. H., Potvin, J. H., Jenike, M. A., Rush, A. J., Dominguez, R. A., Koran, L. M., Shear, K., Goodman, W. K., & Genduso, L. A. (1994). A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder. Archives of General Psychiatry, 51, 559-567.
64. * Vallejo, J., Olivares, J., Marcos, T., Bulbena, A., & Menchon, J. M. (1992). Clomipramine versus phenelzine in obsessive-compulsive disorder: A controlled clinical trial. British Journal of Psychiatry, 161, 665-670.
65. van Balkom, A. J. L. M., van Oppen, P., Vermeulen, A. W. A., van Dyck, R., Nauta, M. C. E., & Vorst, H. C. M. (1994). A meta-analysis on the treatment of obsessive-compulsive disorder: A comparison of antidepressants, behavior, and cognitive therapy. Clinical Psychology Review, 14, 359-381.
66. van Oppen, P., & Arntz, A. (1994). Cognitive therapy for obsessive-compulsive disorder. Behavior Research and Therapy, 32, 79-87.
67. * van Oppen, P., de Haan, E., van Balkom, A. J. L. M., Spinhoven, P., Hoogduin, K., & van Dyck, R. (1995). Cognitive therapy and exposure in vivo in the treatment of obsessive-compulsive disorder. Behavior Research and Therapy, 33, 379-390.
68. * Volavka, J., Neziroglu, F., & Yaryura-Tobias, J. A. (1985). Clomipramine and imipramine in obsessive-compulsive disorder. Psychiatry Research, 14, 83-91.
69. * Zohar, J., & Insel, T. R. (1987). Obsessive-compulsive disorder: Psychobiological approaches to diagnosis, treatment, and pathophysiology. Biological Psychiatry, 22, 667-687.